Management of High Nasal Colonization of Staphylococcus aureus
Asymptomatic Staphylococcus aureus nasal colonization should not be treated unless there is a history of recurrent skin infections or ongoing household transmission.
When to Consider Treatment for Nasal Staph A Colonization
- Decolonization therapy is not routinely recommended for asymptomatic patients with positive Staphylococcus aureus nasal swabs 1
- Treatment should only be considered in the following specific situations:
- Patients with recurrent Staphylococcus aureus skin and soft tissue infections (SSTIs) despite optimizing wound care and hygiene measures 2, 1
- When there is ongoing transmission among household members or other close contacts despite optimizing hygiene measures 2
- Patients at high risk for surgical site infections, particularly those undergoing certain surgical procedures 3
Recommended Decolonization Protocol When Treatment is Indicated
- Nasal decolonization with mupirocin 2% ointment applied to both anterior nares twice daily for 5-10 days 2, 1
- Consider adding topical body decolonization with:
Important Hygiene Measures for All Carriers
- Keep draining wounds covered with clean, dry bandages 2
- Maintain good personal hygiene with regular bathing 1
- Clean hands frequently with soap and water or alcohol-based hand sanitizer 2
- Avoid sharing personal items (razors, linens, towels) that contact skin 2
- Focus cleaning efforts on high-touch surfaces using commercially available cleaners 2
Household Contact Management
- Evaluate symptomatic contacts for evidence of Staphylococcus aureus infection and treat accordingly 2
- Consider nasal and topical body decolonization of asymptomatic household contacts if there is ongoing transmission 2, 1
Monitoring and Follow-up
- Routine surveillance cultures following decolonization are not recommended in the absence of active infection 2, 1
- Be aware that decolonization may only provide temporary clearance, with recolonization occurring after discontinuation 2, 4
Special Considerations
- Age is a risk factor for subsequent infection in colonized patients, with those over 40 years having higher risk 5
- MRSA carriers have a significantly higher risk of subsequent infection compared to MSSA carriers, especially in younger patients 5
- Patients with a prior history of Staphylococcus aureus positive cultures are at higher risk for subsequent infection 5
Potential Pitfalls
- Mupirocin resistance is increasing, which may reduce effectiveness of decolonization strategies 4
- Hexachlorophene should not be used in infants under 2 months of age due to risk of neurological complications 2
- Decolonization without addressing underlying risk factors or environmental contamination may lead to early recolonization 2, 4